Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

Fang T, Al Khleifat A, Meurgey JH, et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging ...

Trethera Treats a Late Stage, Heavily Pretreated Amyotrophic Lateral Sclerosis (ALS) Patient with TRE 515. Mar. 31, 2025 9:30 AM ET. ... Amyotrophic lateral sclerosis (ALS), ...

Recessively inherited amyotrophic lateral sclerosis: a Germany family with the D90A CuZn-SOD mutation. J Neurol 2000;247:783-786. Crossref. PubMed. Web of Science. Google Scholar. 32.

Chicago, June 23, 2025 (GLOBE NEWSWIRE) -- The global amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, reflecting ...

The pathological process underlying amyotrophic lateral sclerosis (ALS) ... Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20–38 (2013).

Amyotrophic lateral sclerosis (ALS) is a rare motor neuron disorder. Currently, ... ALS symptoms typically start in one area of the body (your speech, hands, or legs) in the early stages of the ...

According to the CDC, more than a thousand cases of myocarditis and pericarditis following mRNA COVID-19 vaccination have been reported to the Vaccine Adverse Event Reporting System since April 2021.

Amyotrophic lateral sclerosis, known as ALS, is a neurodegenerative disorder which affects motor neurons. These are the neuronal cells responsible for muscle innervation, whose degenerations leads ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive, inflammatory neurodegenerative disease impacting nerve cells in the brain and spinal cord, reducing ...

To the Editor: In their review of amyotrophic lateral sclerosis (ALS) Rowland and Shneider (May 31 issue)1 state that “the selective vulnerability of motor neurons” to glutamate may be ...